Back to search

Article

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine development

2022-03-11

Abstract excerpt

<h4>Background: </h4> Bladder cancer (BLCA) is a common malignancy from urinary tract. Although the diagnosis and treatment of bladder cancer has made great progress in the past few decades, the effects of existing treatment methods are still limited. Therefore, it is still necessary to develop new methods to assist in the disease management and treatment. Tumor antigens are tumor-specific surface molecules and ar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aef9fd61-2b24-59a4-87b8-3e53d3656f50
DOI
10.21203/rs.3.rs-1433880/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentDOI 10.21203/rs.3.rs-1433880/v1
Select a neighboring publication to make it the new centre.